Medication info

Lipophen MC 20% Injection

Prescription medicationApproval withdrawn
Ingredient · strength
Soybean Oil›Strength being verifiedTriglycerides Medium-Chain›Strength being verified
Manufacturer / importer
B.Braun Korea Co., Ltd
Appearance
A milky white suspension in a glass container for injection
Packaging
100, 250, 500 milliliters x manufacturer's packaging unit
Approval status
Approval withdrawn

MFDS item code 200410466 · Notified 2004.10.25

This product's status changed to Approval withdrawn on 2023.04.27. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Nutritional improvement through the provision of essential fatty acids and calories
Who uses it
Adults · Children
Adult dosage
Infuse intravenously 1∼2 g of fat/kg body weight per day (equivalent to 5∼10 mL of this product). In general, administer the lipid emulsion as slowly as possible. During the first 15 minutes, do not exceed 0.05∼0.1 g of fat/kg body weight per hour (equivalent to 0.25∼0.5 mL of this product). If no significant adverse effects occur, the infusion rate may be increased to 0.15∼0.2 g of fat/kg body weight per hour (equivalent to 0.75∼1.0 mL of this product). Administer for at least 16 hours per day; continuous administration over 24 hours or longer is recommended. Treatment is generally continued for 1∼2 weeks or longer, and may be extended with appropriate monitoring if necessary.
Children's dosage
Neonates: Infuse intravenously 2∼3 g of fat/kg body weight per day (equivalent to 10∼15 mL of this product). Up to a maximum of 4 g of fat/kg body weight per day (equivalent to 20 mL of this product) may be administered. Infants: Infuse intravenously 1∼3 g of fat/kg body weight per day (equivalent to 5∼15 mL of this product).

Ingredients

Importer
B.Braun Korea Co., Ltd

Efficacy & effects

Nutritional improvement through the provision of essential fatty acids and calories

View approved original text

This medication is used to improve the nutritional status of patients requiring parenteral nutrition by supplying essential fatty acids and adequate calories.

Dosage and Administration

Adult dosage

Infuse intravenously 1∼2 g of fat/kg body weight per day (equivalent to 5∼10 mL of this product). In general, administer the lipid emulsion as slowly as possible. During the first 15 minutes, do not exceed 0.05∼0.1 g of fat/kg body weight per hour (equivalent to 0.25∼0.5 mL of this product). If no significant adverse effects occur, the infusion rate may be increased to 0.15∼0.2 g of fat/kg body weight per hour (equivalent to 0.75∼1.0 mL of this product). Administer for at least 16 hours per day; continuous administration over 24 hours or longer is recommended. Treatment is generally continued for 1∼2 weeks or longer, and may be extended with appropriate monitoring if necessary.

Children's dosage

Neonates: Infuse intravenously 2∼3 g of fat/kg body weight per day (equivalent to 10∼15 mL of this product). Up to a maximum of 4 g of fat/kg body weight per day (equivalent to 20 mL of this product) may be administered. Infants: Infuse intravenously 1∼3 g of fat/kg body weight per day (equivalent to 5∼15 mL of this product).

Precautions

This medication should be used with great caution when administered to premature infants and low-birth-weight infants, as it may increase plasma free fatty acid levels. It should not be administered to premature infants with severe respiratory diseases, as this may lead to serious complications due to fat accumulation in the pulmonary vasculature. It should not be used in patients with pathological hyperlipidemia, lipid metabolism disorders, ketoacidosis, hypoxia, thrombosis, acute myocardial infarction, or liver disease. It is also contraindicated in pregnant women, and patients with a history of allergic reactions should be observed closely. Caution should be exercised in patients suspected of metabolic acidosis, pulmonary disease, anemia, or fat embolism. During administration, blood tests, liver function tests, and platelet counts should be closely monitored, and administration should be stopped immediately if adverse reactions occur. This medication should be given slowly while carefully monitoring blood lipid levels, as rapid administration can cause fluid imbalance or lung damage. Diabetic patients should be especially cautious, as ketoacidosis may worsen. The safety of this drug in pregnant or nursing women has not been established; it should only be used when absolutely necessary, with thorough monitoring through various tests. In children, especially premature and low-birth-weight infants, due to immature fat excretion capacity, the dosage should be limited, and blood lipid levels should be carefully monitored. In the case of overdose, symptoms such as liver enlargement, anemia, and coagulopathy may appear, and administration should be stopped immediately, followed by appropriate treatment. This medication must be administered exclusively through a peripheral venous infusion, should not be mixed with other medications, and any remaining medication should be discarded. Additionally, it is recommended to administer more than 40% of the total calories along with carbohydrates.

Side effects

Thrombocytopenia, leukopenia, brown pigmentation in the reticuloendothelial system, hepatomegaly, cholestatic jaundice in centrilobular areas, transient increase in liver function tests, dyspnea, congestive hypoventilation, hyperlipidemia, coagulopathy, cyanosis, nausea, vomiting, allergic reactions, headache, flushing, high fever, sweating, chills, drowsiness, chest pain, back pain, dizziness, edema, overload syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a cool place below 25 degrees Celsius, in a sealed container to avoid contact with air. This will help maintain the effectiveness of the drug.

Appearance and packaging

Appearance

A milky white suspension in a glass container for injection

Package unit

100, 250, 500 milliliters x manufacturer's packaging unit

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.